Seizert Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.27M | Sell |
37,822
-1,044
| -3% | -$146K | 0.24% | 67 |
|
|
2025
Q4 | $4.77M | Sell |
38,866
-602
| -2% | -$73.2K | 0.2% | 70 |
|
|
2025
Q3 | $4.38M | Sell |
39,468
-7,791
| -16% | -$886K | 0.19% | 78 |
|
|
2025
Q2 | $5.24M | Hold |
47,259
| – | – | 0.23% | 71 |
|
|
2025
Q1 | $5.3M | Buy |
47,259
+58
| +0.1% | +$5.99K | 0.24% | 67 |
|
|
2024
Q4 | $4.36M | Sell |
47,201
-2,063
| -4% | -$186K | 0.2% | 87 |
|
|
2024
Q3 | $4.13M | Buy |
49,264
+119
| +0.2% | +$9.08K | 0.19% | 95 |
|
|
2024
Q2 | $3.37M | Sell |
49,145
-7,255
| -13% | -$484K | 0.17% | 90 |
|
|
2024
Q1 | $4.13M | Sell |
56,400
-2,205
| -4% | -$170K | 0.19% | 80 |
|
|
2023
Q4 | $4.75M | Sell |
58,605
-26,178
| -31% | -$2.04M | 0.24% | 74 |
|
|
2023
Q3 | $6.35M | Buy |
84,783
+229
| +0.3% | +$17.6K | 0.34% | 57 |
|
|
2023
Q2 | $6.52M | Sell |
84,554
-8,704
| -9% | -$694K | 0.35% | 59 |
|
|
2023
Q1 | $7.74M | Sell |
93,258
-26,738
| -22% | -$2.21M | 0.43% | 55 |
|
|
2022
Q4 | $10.3M | Sell |
119,996
-11,797
| -9% | -$934K | 0.55% | 49 |
|
|
2022
Q3 | $8.13M | Sell |
131,793
-565
| -0.4% | -$35.6K | 0.46% | 56 |
|
|
2022
Q2 | $8.18M | Buy |
132,358
+6,845
| +5% | +$424K | 0.43% | 55 |
|
|
2022
Q1 | $7.46M | Buy |
125,513
+574
| +0.5% | +$36.7K | 0.34% | 64 |
|
|
2021
Q4 | $9.07M | Buy |
124,939
+997
| +0.8% | +$68.7K | 0.41% | 58 |
|
|
2021
Q3 | $8.66M | Buy |
123,942
+3
| +0% | +$211 | 0.4% | 59 |
|
|
2021
Q2 | $8.53M | Buy |
123,939
+3,639
| +3% | +$243K | 0.41% | 60 |
|
|
2021
Q1 | $7.78M | Buy |
+120,300
| New | +$7.76M | 0.41% | 64 |
|
|
2020
Q4 | – | Sell |
-10,184
| Closed | -$644K | – | 195 |
|
|
2020
Q3 | $644K | Hold |
10,184
| – | – | 0.04% | 135 |
|
|
2020
Q2 | $784K | Sell |
10,184
-260,098
| -96% | -$19.9M | 0.05% | 123 |
|
|
2020
Q1 | $20.2M | Sell |
270,282
-343,053
| -56% | -$23.7M | 1.49% | 28 |
|
|
2019
Q4 | $39.9M | Buy |
613,335
+28,151
| +5% | +$1.83M | 1.98% | 17 |
|
|
2019
Q3 | $37.1M | Sell |
585,184
-19,122
| -3% | -$1.25M | 1.87% | 19 |
|
|
2019
Q2 | $40.8M | Sell |
604,306
-43,877
| -7% | -$2.89M | 2.01% | 19 |
|
|
2019
Q1 | $42.1M | Buy |
648,183
+64,231
| +11% | +$4.27M | 1.89% | 19 |
|
|
2018
Q4 | $36.5M | Sell |
583,952
-67,389
| -10% | -$4.71M | 1.65% | 19 |
|
|
2018
Q3 | $50.3M | Buy |
651,341
+16,972
| +3% | +$1.28M | 1.85% | 16 |
|
|
2018
Q2 | $47.8M | Hold |
634,369
| – | – | 1.74% | 16 |
|
|
2018
Q1 | $47.8M | Buy |
634,369
+724
| +0.1% | +$57.6K | 1.74% | 16 |
|
|
2017
Q4 | $45.4M | Buy |
633,645
+40,656
| +7% | +$3.09M | 1.63% | 22 |
|
|
2017
Q3 | $48M | Sell |
592,989
-38,280
| -6% | -$2.93M | 1.76% | 18 |
|
|
2017
Q2 | $44.7M | Sell |
631,269
-1,305
| -0.2% | -$86.8K | 1.62% | 24 |
|
|
2017
Q1 | $43M | Buy |
632,574
+27,547
| +5% | +$1.94M | 1.53% | 25 |
|
|
2016
Q4 | $43.3M | Buy |
605,027
+7,899
| +1% | +$587K | 1.54% | 21 |
|
|
2016
Q3 | $47.2M | Sell |
597,128
-13,737
| -2% | -$1.12M | 1.75% | 16 |
|
|
2016
Q2 | $51M | Sell |
610,865
-56,487
| -8% | -$5.01M | 1.93% | 11 |
|
|
2016
Q1 | $61.3M | Buy |
667,352
+151,118
| +29% | +$13.6M | 2.09% | 6 |
|
|
2015
Q4 | $52.2M | Buy |
516,234
+10,647
| +2% | +$1.11M | 1.63% | 23 |
|
|
2015
Q3 | $49.6M | Buy |
505,587
+63,722
| +14% | +$7.08M | 1.5% | 26 |
|
|
2015
Q2 | $51.7M | Buy |
441,865
+18,434
| +4% | +$2.01M | 1.32% | 38 |
|
|
2015
Q1 | $41.6M | Sell |
423,431
-30,080
| -7% | -$3.05M | 1.05% | 45 |
|
|
2014
Q4 | $42.7M | Buy |
453,511
+191,752
| +73% | +$19.8M | 0.9% | 52 |
|
|
2014
Q3 | $27.9M | Buy |
261,759
+1,602
| +0.6% | +$157K | 0.56% | 65 |
|
|
2014
Q2 | $21.6M | Buy |
260,157
+13,495
| +5% | +$1.05M | 0.43% | 67 |
|
|
2014
Q1 | $17.5M | Sell |
246,662
-3,426
| -1% | -$269K | 0.41% | 67 |
|
|
2013
Q4 | $18.8M | Sell |
250,088
-66,510
| -21% | -$4.63M | 0.44% | 64 |
|
|
2013
Q3 | $19.9M | Sell |
316,598
-76,950
| -20% | -$4.6M | 0.54% | 60 |
|
|
2013
Q2 | $20.2M | Buy |
+393,548
| New | +$20.5M | 0.55% | 58 |
|
Other funds holding GILD
VCM
VPM
Seizert Capital Partners's GILD Position: Q1 2026 in Review
Seizert Capital Partners reduced its Gilead Sciences (GILD) stake by 2.7% in Q1 2026, selling an estimated $146K and leaving 37,822 shares worth $5.27M. The position accounts for 0.24% of the portfolio, ranked #67.
Seizert Capital Partners first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $61.3M in Q1 2016. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Seizert Capital Partners held 37,822 shares of Gilead Sciences worth $5.27M as of Q1 2026.
- Seizert Capital Partners sold 1,044 Gilead Sciences shares in Q1 2026, an estimated $146K.
- Gilead Sciences made up 0.24% of Seizert Capital Partners's portfolio in Q1 2026, its #67 holding.
- Seizert Capital Partners first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
- Seizert Capital Partners's Gilead Sciences position peaked at $61.3M in Q1 2016.
- 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Seizert Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.